Abstract
We describe four phenotypically different brothers who share the same microduplication of Xq27.1, which contains the SOX3 gene. SOX3 mutations have been associated with growth hormone deficiency, variable degrees of additional pituitary hormone deficiencies, and mental retardation. SOX3 also appears to play an important role in pharyngeal arch segmentation that gives rise to craniofacial structures. While these four brothers have inherited the same mutation, they manifest a spectrum of phenotypes, ranging from complete, multiple pituitary hormone deficiencies to no apparent pituitary hormone deficiency with or without craniopharyngeal/facial dysmorphisms. We look to the literature to provide putative explanations for the variable expression of the brothers’ shared SOX3 mutation.
Acknowledgments
We are grateful to the parents of the children described in this article, who have generously provided consent and feedback.
References
1. de Moraes DC, Vaisman M, Conceição FL, Ortiga-Carvalho TM. Pituitary development: a complex, temporal regulated process dependent on specific transcriptional factors. J Endocrinol 2012;215:239–45.10.1530/JOE-12-0229Search in Google Scholar
2. Nose O, Tatsumi K, Nakano Y, Amino N. Congenital combined pituitary hormone deficiency attributable to a novel PROP1 mutation (467insT). J Pediatr Endocrinol Metab 2006;19:491–8.Search in Google Scholar
3. Zipf WB, Kelch RP, Bacon GE. Variable X-linked recessive hypopituitarism with evidence of gonadotropin deficiency in two pre-pubertal males. Clin Genet 1977;11:249–54.10.1111/j.1399-0004.1977.tb01309.xSearch in Google Scholar
4. Woods KS, Cundall M, Turton J, Rizotti K, Mehta A, et al. Over- and underdosage of SOX3 is associated with infudibular hypoplasia and hypopituitarism. Am J Hum Genet 2005;76:833–49.10.1086/430134Search in Google Scholar
5. Stagi S, Lapi E, Pantaleo M, Traficante G, Giglio S, et al. SOX3 (Xq26.3-27.3) duplication in a boy with growth hormone deficiency, ocular dyspraxia, and intellectual disability: a long term follow-up and literature review. Hormones (Athens) 2014;13:552–60.10.14310/horm.2002.1523Search in Google Scholar
6. Hamel B, Smits A, Oheen BJ, van den Helm B, Ropers HH, et al. Familial X-linked mental retardation and isolated growth hormone deficiency. Am J Med Genet 1996;64:35–41.10.1002/(SICI)1096-8628(19960712)64:1<35::AID-AJMG5>3.0.CO;2-QSearch in Google Scholar
7. Lagerström-Fermér M, Sundvall M, Johnsen E, Warne GL, Forrest SM, et al. X-linked recessive panhypopituitarism associated with a regional duplication in Xq25-q26. Am J Hum Genet 1997;60:910–6.Search in Google Scholar
8. Solomon NM, Ross SA, Morgan T, Belsky JL, Hol FA, et al. Array comparative genomic hybridization analysis of boys with X-linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3. J Med Genet 2004;41:669–78.10.1136/jmg.2003.016949Search in Google Scholar
9. Laumonnier F, Ronce N, Hamel BC, Thomas P, Lespinasse J, et al. Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency. Am J Hum Genet 2002;71:1450–5.10.1086/344661Search in Google Scholar
10. Hol FA, Schepens MT, van Beersum SE, Redolfi E, Affer M, et al. Identification and characterization of an Xq26-27 duplication in a family with spina bifida and panhypopituitarism suggests the involvement of two distinct genes. Genomics 2000;69:174–81.10.1006/geno.2000.6327Search in Google Scholar
11. Solomon NM, Ross SA, Forrest SM, Thomas PQ, Morgan T, et al. Array comparative genomic hybridisation analysis of boys with X-linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3. (Letter) J Med Genet 2007;44:e75.10.1136/jmg.2007.049049Search in Google Scholar
12. Bauters M, Frints SG, Van Esch H. Evidence for increased SOX3 dosage as a risk factor for X-linked hypopituitarism and neural tube defects. Am J Med Genet 2014;164:1947–52.10.1002/ajmg.a.36580Search in Google Scholar
13. Alatzoglou KS, Kelberman D, Daheani MT. The role of SOX proteins in normal pituitary development. J Endocrinol 2009;200:245–58.10.1677/JOE-08-0447Search in Google Scholar PubMed
14. Moalem S, Babul-Hirji R, Stavropolous DJ, Wherrett D, Bagli DJ, et al. XX male sex reversal with genital abnormalities associated with a de novo SOX3 gene duplication. Am J Med Genet A 2012;158A;1759–64.10.1002/ajmg.a.35390Search in Google Scholar PubMed
15. Rizzoti K, Brunelli S, Carmignac D, Thomas PQ, Robinson IC, et al. SOX3 is required during the formation of the hypothalamo-pituitary axis. Nat Genet 2004;36:247–55.10.1038/ng1309Search in Google Scholar PubMed
16. Rizzoti K, Lovell-Badge R. SOX3 activity during pharyngeal segmentation is required for craniofacial morphogenesis. Development 2007;134:3437–48.10.1242/dev.007906Search in Google Scholar PubMed
17. Wegner M, Stolt CC. From stem cells to neurons and glia: a Soxist’s view of neural development. Trends Neurosci 2005;28:583–8.10.1016/j.tins.2005.08.008Search in Google Scholar PubMed
18. Tziaferi V, Kelberman D, Dattani MT. The role of SOX2 in hypogonadotropic hypogonadism. Sex Dev 2008;2:194–9.10.1159/000152035Search in Google Scholar PubMed
©2020 Walter de Gruyter GmbH, Berlin/Boston
